We advised Maseera Holding Limited, a subsidiary of 2PointZero—a transformational global investment platform and a subsidiary of International Holding Company (IHC)—in its 100% acquisition of the share capital of Maseera Holding for Financial Investments S.A.E. 

This strategic acquisition underscores the growing importance of non-banking financial services in Egypt’s expanding formal economy. Investing in this sector not only drives economic returns but also fosters job creation and accelerates development, aligning with Egypt Vision 2030 and enhancing financial inclusion.

Our team was led by Ibrahim ElGengehy, Partner, Ibrahim ElMessery, Counsel, and Yomna Taha, Senior Associate.

We extend our congratulations to Amro Abouesh, Founder and CEO of Maseera on this achievement.

We are also pleased to have worked alongside our colleagues Mohamed Ghannam, Managing Partner, Chirouette Elmasry, Associate at Helmy, Hamza & Partners - Baker Mckenzie, legal advisors to Maseera Holding for Financial Investments S.A.E.  


For more information, check out Zawya coverage here.

We are pleased to announce ADSERO’s contribution to the Pharmaceutical & Medical Devices Comparative Guide by Mondaq. This article offers key insights into Egypt’s legal and regulatory frameworks, covering key aspects such as legislative provisions and enforcement bodies.

Our insights are provided by our Life Sciences team Fadila Abdelaziz, Counsel; Shaimaa Adel Abdelhakim, Senior Associate; and Fagr Muheb, Managing Associate, with the assistance of Junior Associates Ahmed Yasser, Ameerah Abdelnaeem and Hannah Mahran.

Read the full guide here.

Ragy Soliman, Managing Partner, Co-Head of M&A and Capital Markets, shares insights on the growing demand for cost transparency in legal services across Africa, as featured in a recent IFLR report.

Read how ADSERO and other legal experts are addressing this critical need in the region in the publication below.

What Corporates Want_Economic pressures in Africa drive need for legal cost transparencyDownload

Introduction:

On 9 February, Egypt introduced new amendments to key maritime laws through the enactment of Law No. 2, Law No. 3, and Law No. 4 of 2025, impacting ship safety, maritime trade, and vessel registration. These amendments aim to enhance regulatory oversight, streamline registration processes, and enforce stricter compliance standards for vessels operating under the Egyptian flag.

Key Amendments:

1. Law No. 2 of 2025: Amendments to the Ship Safety Law (Law No. 232 of 1989)

2. Law No. 3 of 2025: Amendments to the Maritime Trade Law (Law No. 8 of 1990)

3. Law No. 4 of 2025: Amendments to the Ship Registration Law (Law No. 84 of 1949)

If you have any questions, please do not hesitate to contact our team members, Hossam Gramon, Partner, Head of Banking & Project Finance, and Laila Shoukry, Managing Associate.

We are pleased to share our most recent report highlighting the critical decisions issued by the Board of Directors of the Financial Regulatory Authority (FRA) during the second half of 2024.

To access the second issue, click on the attachment below.

Key Decisions Issued by the Financial Regulatory AuthorityDownload

Introduction:

In alignment with recent presidential directives aimed at enhancing social justice and improving the standard of living for Egyptian citizens, the National Wages Council (“NWC”) convened on Sunday, 9 February 2025, to discuss raising the private sector’s minimum wage and determining the statutory annual increment percentage for 2025.

The meeting was attended by key government officials, including the Minister of Supply and Internal Trade, the Minister of Social Solidarity, the Minister of the Public Business Sector, the Minister of Labour, the Chairman of the National Council for Women, the Chairman of the Central Agency for Public Mobilization and Statistics, the Chairman of the Central Agency for Organization and Administration, the Director of the Labour Market Policies Unit at the Ministry of Planning, Economic Development, and International Cooperation, the Advisor to the NWC, and the Legal Counsel of the NWC.

Overview:

In response to recent presidential directives focused on social justice and improved living standards, the NWC has approved an increase in the private sector minimum wage. Accordingly, the NWC has decided to raise the minimum wage for private sector employees to EGP 7,000 (seven thousand Egyptian pounds), up from EGP 6,000 (six thousand Egyptian pounds), effective 1 March 2025, formalised under Ministerial Decree No. 15 of 2025.

Additionally, the NWC has set the minimum statutory annual increment for private sector employees at 3% of their social insurance subscription wage, with a minimum of EGP 250 (two hundred and fifty Egyptian pounds) for the 2025 fiscal year, instead of EGP 200 (two hundred Egyptian pounds) as per the most recent decree for 2024.

Furthermore, for the first time, the NWC has introduced a minimum hourly wage for employees working in temporary jobs, setting the net base rate at EGP 28 per hour.

Concerned Entities:

If you have any questions, please do not hesitate to contact our team members, Alia Monieb, Partner, Head of Employment, and Nada Khaled, Senior Associate.

We are pleased to share ADSERO’s ranking in the Chambers and Partners Global Guide 2025.

This year, ADSERO’s rankings, which include 5 practice areas and 6 ranked lawyers, reaffirm our firm’s continued growth and diversification. These achievements solidify our position as a leading firm in Egypt, uniquely positioned to deliver comprehensive legal solutions and facilitate seamless cross-border transactions within the MENA region and beyond.

A special congratulations to Osman Mowafy – Senior Partner, Head of Dispute Resolution: Litigation, and Hossam Gramon – Partner, Head of Banking & Project Finance, for their individual rankings! We also extend our congratulations to all of our ranked partners and team members whose expertise and dedication have made this recognition possible.

To view our full rankings, click here.

C&P Rankings 2025Download

We are pleased to share our latest report highlighting the laws and decrees issued in the fourth quarter of 2024.

To access the report, click on the attachment below.

If you are interested in acquiring a copy of the legislation and keen on remaining up to date with the most recent laws and decrees, sign up here.

Q4 of 2024Download


We are pleased to have advised the Ministry of Finance in Egypt (MOF) on its first USD bond issuance in nearly two years, issuing USD 2 billion in 5- and 8-year bonds.

This significant transaction marks a crucial step in Egypt's efforts to re-enter the global bond market, leveraging rising investor interest in Egyptian debt. 

Our team was led by Hossam Gramon, Partner and Head of Banking & Project Finance, and Karima Seyam, Senior Associate, assisted by Junior Associates Mostafa Serry, Nour El Kholy, and Nour Osama.

We are pleased to have worked alongside our esteemed colleagues from Dechert LLP, the international counsel to the MOF; Linklaters; the international counsel to the banks; and Zaki Hashem, Attorneys at Law, local counsel to the banks.

It was a pleasure to collaborate with the teams at J.P. Morgan Securities, Citi, Goldman Sachs, Standard Chartered, Sumitomo Mitsui Banking Corporation - SMBC Group, and HSBC.


Congratulations to our client, MOF, on this groundbreaking achievement!


For more information, check out The Enterprise Company's coverage here.

We are pleased to announce ADSERO - Ragy Soliman & Partners' contribution to the Q4 edition of the Global Guide Quarterly (GGQ) published by Littler. Our insights, provided by Alia Monieb, Partner and Head of Employment, and Nada Khaled, Senior Associate, highlight key developments in labour and employment (L&E) law in Egypt.

The GGQ is a quarterly newsletter that offers concise coverage of global L&E law developments in key countries across the Americas, Asia-Pacific, Europe, the Middle East, and Africa. It serves as an essential resource for multinational enterprises to stay informed about important changes in the L&E law framework.

Read our overview here.

Introduction

Given the recent significant increase in dietary supplements’ consumption and the debate surrounding their classification; this document presents an overview on the current categorisation & regulatory framework of the same in Egypt.

Definition

A dietary supplement (“Supplement”) is mainly defined as a product that:

  1. Is intended to augment the nutritional value of everyday food intake, including vitamins, minerals, and other ingredients with nutritional or physiological effects;
  2. is not intended to treat, diagnose, cure, or alleviate disease; and
  3. is usually sold in dosage form such as capsules, soft gels, tablets, ampoules, pills, and sachets of powder, and taken in measured doses.

Background

The Ministry of Health and Population used to be responsible for Supplements’ licensing and registration in Egypt, until the establishment of the National Food Safety Authority (“NFSA”); which assumed this responsibility ever since 2018.

However, in 2022, the Egyptian Drug Authority (“EDA”) introduced a new category of pharmaceuticals called “complementary pharmaceuticals.” These products contain an active ingredient or groups of active ingredients with a complementary medical impact used to help treat, prevent, restore, or adjust physiological functions.

It is worth highlighting that certain types of dietary supplements are designed to improve overall health or assist in managing specific health conditions. Such types would fall under the previously mentioned category of complementary pharmaceuticals. As a result, these supplements are now subject to the EDA’s authority.

Categorisation and Governance

In March 2023, the EDA and the NFSA established the “White List” mechanism, which categorises dietary supplements based on their concentration level. The said concentration level determines whether a Supplement falls under the licensing jurisdiction of the NFSA or the EDA. Hence, the lists set forth the maximum concentration levels for a Supplement to qualify as a food supplement with the NFSA, while exceeding these levels requires registration with the EDA.

Perspective

Although Supplements are processed foods intended to help individuals obtain adequate amounts of essential nutrients when they are unable to consume a varied and nutritious diet, many Supplements contain active ingredients that can have strong effects on the human body (e.g., increasing the risk of bleeding or potentially alerting the response to anesthesia if taken before surgery). The risk is increased by taking multiple Supplements simultaneously, or at high doses, or in combination with contradicting medicines.

Needless to mention the various victims who have been harmed by the unsupervised and excessive use of Supplements, particularly since 2020, with cases including liver damage and bone weakness. Ultimately, Supplements cannot replace the diverse range of foods necessary for maintaining a healthy body and a strong immune system.

Therefore, the high risks associated with the public’s insufficient awareness of these aforementioned issues provide a strong rationale for the EDA’s involvement in protecting public wellbeing and preventing having more lives at stake.

Lastly, it is worth noting that due to the strict regulations governing pharmaceuticals’ licensing and registration in Egypt (including compulsory pricing and exclusive availability through pharmaceutical institutions), Supplement manufacturers will often be more inclined to register their products with the NFSA over the EDA. This explains why, back in 2022, some Supplements’ manufacturers expressed dissatisfaction with the EDA’s sudden involvement in the Supplements’ industry, which could potentially impact investment. Nonetheless, the EDA remains a key player through the White List mechanism, as safeguarding public health remains the ultimate priority.

Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of ADSERO. This article is intended for general information purposes only and should not be considered or relied on as legal advice. Readers are encouraged to consult with a qualified attorney for specific legal guidance. ADSERO does not guarantee or warrant the accuracy, completeness, or adequacy of the information provided and accepts no liability or responsibility for any errors or omissions in the content.

We are pleased to share ADSERO’s contribution to the newly updated International Employment Lawyer’s (IEL) Guide to Workplace Investigations. As the importance of ESG rises, this guide addresses key challenges in conducting fair and thorough investigations, providing insights into governance, compliance, and legal risk management.

Contributed by Alia Monieb, Partner and Head of Employment; Rawan Roshdy, Managing Associate; Hoda Khira, Junior Associate; and Khaled Omar, Junior Associate, the Egyptian chapter provides practical guidance on initiating, conducting, and concluding workplace investigations while addressing critical legal and operational considerations.

Explore the guide and learn more about workplace investigations protections across various jurisdictions here.

We are delighted to share our recent contribution to the third edition of The Legal Industry Reviews (LIR) in Egypt.

In our chapter, "Modernising Egypt’s Digital Framework: New Decrees on E-Signatures and Registered Email Services," we explore two key MCIT regulations: the Postal Decree No. 250 of 2024 and the E-Signature Decree No. 467 of 2024. These regulations advance the legal framework for electronic transactions, enhancing the integrity, authenticity, and legal validity of digital communications while addressing challenges posed by overlapping authorities.

This article is authored by Darah Zakaria, Counsel, Aya Yassin, Senior Associate, and Hana Ayman, Junior Associate.

To read our contribution, click here (pages 48-49).

We advised the sellers, Ayady Egypt for Investment & Development (Ayady), NI Capital Holding for Financial Investments (NI Capital), and Post For Investment (PFI), on the divestment of Tamweely Microfinance (Tamweely), Egypt’s leading microfinance provider, in a landmark deal exceeding EGP 2.5 billion by a consortium of investors, including SPE Capital , European Bank for Reconstruction and Development (EBRD), Tanmiya Capital Ventures (TCV), and British International Investment (BII) and the transaction was successfully closed on 31 December 2024.

This acquisition highlights international confidence in Egypt’s non-banking financial sector, promoting financial inclusion by enabling Tamweely to expand its services to underserved populations. It also marks a strategic exit for government entities, aligning with Egypt's policy to encourage private sector growth. With strong global backing, Tamweely is set for continued expansion, supporting MSMEs across the country.

Our team was led by partners Ahmed Abdelgawad and Ibrahim ElGengehy; Ibrahim El Messery, Counsel; and Soha Hussein, Associate; Youssef Abelkader, Junior Associate.

Congratulations to Mohamed Metwally, Chief Executive Officer at NI Capital; Hazem Kamel, Managing Director - Private Equity at NI Capital; Soliman S. AlTayyar, Vice President - Private Equity & Venture Capital at NI Capital; and Sandra Wadei, Senior Investment Analyst at NI Capital. We also extend our congratulations to Ayady, PFI, and Tamweely.

We are pleased to have worked alongside our colleagues Ahmed Eloraby, partner at SPE, and Farida Abaza, Associate at SPE, as well as Hani Nassef, parner at Helmy, Hamza & Partners - Baker McKenzie; Bassem Abdelrahman, Counsel at Helmy, Hamza, & Partners - Baker Mckenzie; and Hayna Abdelrahim, Associate at Helmy, Hamza, & Partners - Baker Mckenzie; and our colleagues at A&O Shearman, English Counsel to the sellers, on this groundbreaking deal.

For more information, check out Amwal Al Ghad - اموال الغد's coverage here and the Ministry of International Cooperation's coverage here.

Key Highlights:

The Egyptian government has introduced a draft law titled the "Medical Liability and Patient Protection Law." This significant legislative development aims to regulate medical liability, ensure patient protection, and uphold ethical standards within the healthcare sector. The proposed legislation is subject to public consultations and parliamentary discussions before being enacted.

Scope and Objectives:

Key Provisions:

  1. Formation of Medical Liability Committees: These specialised committees will assess cases of alleged medical malpractice, ensuring impartial and expert evaluations.
  2. Compensation Mechanisms: Provisions for compensating patients for proven damages arising from medical negligence.
  3. Penalties for Violations: Clear delineation of penalties for medical practitioners found guilty of gross misconduct or negligence.
  4. Mandatory Malpractice Insurance: Ensures financial coverage for claims against healthcare providers.

Impact on Healthcare Providers:

The draft law introduces a structured and comprehensive framework that could significantly impact healthcare providers, including clinics, hospitals, and individual practitioners. At its core, the law aims to protect medical professionals from unwarranted litigation by establishing impartial committees to review claims of medical malpractice. This process seeks to reduce the risk of frivolous lawsuits, providing healthcare providers with a fair platform to defend their actions based on expert evaluations.

However, the law also imposes stringent compliance requirements, such as the mandatory maintenance of detailed and accurate medical records for each patient, the adoption of standardised protocols for medical procedures, and the securing of malpractice insurance coverage. These measures are designed to enhance patient safety and accountability but may result in increased administrative and financial burdens for healthcare providers. For smaller clinics and individual practitioners, the costs associated with insurance premiums and compliance upgrades could be particularly challenging.

Additionally, the law’s compensation mechanisms for proven cases of negligence may necessitate healthcare providers to re-evaluate their risk management practices. Providers will need to adopt proactive measures, such as regular staff training, updated medical equipment, and adherence to stringent clinical guidelines, to minimise the risk of liability. Non-compliance or failure to meet these obligations could expose providers to reputational risks, financial penalties, or even operational constraints.

In light of these changes, healthcare providers are encouraged to undertake a thorough review of their current practices and identify areas requiring alignment with the proposed regulations. By doing so, providers can ensure smoother compliance with the law while safeguarding their patients and professional standing in an evolving legal landscape.

Next Steps:

The draft law will undergo public consultations to incorporate feedback from stakeholders, including medical professionals, patient advocacy groups, and legal experts. Following this, it will be presented to Parliament for further deliberation and possible enactment.

ADSERO will closely monitor the progress of this legislation and provide updates on its impact on healthcare providers and patients alike.

If you have questions regarding the draft law or its potential implications for your organisation, please do not hesitate to contact our team members, Mohamed Fathy, Partner and Head of Real Estate, Tourism and Life Sciences; and Fadila Abdelaziz, Counsel.

STAY UPDATED WITH NEWS SUBSCRIBE TO OUR NEWSFEED


    Top linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram